Patients with early-stage breast cancer experience distinct long-term trajectories of cognitive function, a recent Singapore study has shown. Moreover, the risk of cognitive impairment during survivorship appears to be higher in those with self-perceived declines in cognitive function during chemotherapy.
Individuals with major depressive disorder (MDD) have lower odds of testing seropositive for measles despite previous immunization, according to a study. This suggests that MDD may increase susceptibility to the infection due to impaired maintenance of vaccine-related protection against measles.
Those who are cognitively impaired are more likely to develop frailty after 4 years, leading to impairment in motor activities, delayed recall, poorer quality of life and increased mortality rate, a study in Hong Kong recently showed.
It appears that depression and hopelessness do increase the risk of suicide, but effects are weaker than anticipated, according to the results of a meta-analysis. This may be due to several methodological constraints seen across the existing literature.
A recent study demonstrated that the depression treatment programme, Depression Care for People with Cancer (DCPC), did not improve survival among patients from the SMaRT Oncology-2 or SMaRT Oncology-3 trials.
One third of women who have been in a relationship have experienced some form of physical and/or sexual violence by their intimate partner in their lifetime, and pregnant women are particularly vulnerable to domestic violence and abuse (DVA), said President of RCOG Professor Lesley Regan at the recent RCOG World Congress 2018 in Singapore.
Patients with schizophrenia may benefit from cannabidiol treatment, which produces significant improvements in psychotic symptoms and modest positive effects on cognitive performance and overall functioning, according to a recent study.